Total Visits

Views
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany135

Total Visits Per Month

January 2021February 2021March 2021April 2021May 2021June 2021July 2021
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany1112104

File Downloads

Views
Christensen.pdf168
Christensen_et_al-2016-Vaccine-AM.pdf3

Top country views

Views
United States60
Germany18
United Kingdom11
France10
China9
Ireland2
Poland2
United Arab Emirates1
Austria1
Belgium1

Top cities views

Views
Ashburn31
Fairfield9
Beijing4
Boardman4
Oakland4
Southend3
London2
Warsaw2
Beverst1
Bielefeld1